Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients

被引:34
作者
Chamorro, A
Cervera, A
Castillo, J
Dávalos, A
Aponte, JJ
Planas, AM
机构
[1] Hosp Clin Univ, Serv Neurol, Barcelona 08036, Spain
[2] Complejo Hosp Univ, Dept Neurol, Santiago De Compostela 15706, Spain
[3] Hosp Univ Doctor Josep Trueta, Neurol Sect, Girona 17001, Russia
[4] Hosp Clin Univ, Barcelona 08036, Spain
[5] CSIC, IIBB, Dept Pharmacol & Toxicol, Barcelona 08036, Spain
关键词
cerebrovascular disease; heparin; aspirin; cytokines; vascular cell adhesion molecule-1; inflammation; outcome;
D O I
10.1016/S0304-3940(02)00518-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We sought to assess the anti-inflammatory properties of unfractionated heparin (UFH) in patients with ischemic stroke treated within 24 h from the onset of symptoms. We studied prospectively 167 patients that received 1000 IU/h intravenous UFH (n = 70) or 300 mg oral aspirin (n = 97) at a mean treatment delay of 6.7 h. Repeated plasma levels of interleukin (IL)-6, IL-10, IL-4, tumor necrosis factor (TNF)-alpha, soluble intercellular adhesion molecule-1 (sICAM-1), and soluble vascular cell adhesion molecule-1 (sVCAM-1) were compared in both groups using multivariate analyses. Whereas TNF-alpha and sICAM-1 decreased at 48 h, IL-6, IL-4, and sVCAM-1 increased compared with baseline values (P < 0.01). The rise of sVCAM-1 levels at 48 h was significantly lower in patients treated with UFH (P = 0.017) and a two-fold increase of baseline sVCAM-1 was an independent predictor of poor outcome (odds ratio, 2.19,1.1-4.39). These results suggest that adjusted high-dose UFH has anti-inflammatory effects which might improve recovery if administered early after stroke onset. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 21 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   INITIATION OF COAGULATION BY TISSUE FACTOR [J].
BACH, RR .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1988, 23 (04) :339-368
[3]   A longitudinal prospective study of soluble adhesion molecules in acute stroke [J].
Bitsch, A ;
Klene, W ;
Murtada, L ;
Prange, H ;
Rieckmann, P .
STROKE, 1998, 29 (10) :2129-2135
[4]   Soluble intercellular adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke [J].
Blann, A ;
Kumar, P ;
Krupinski, J ;
McCollum, C ;
Beevers, DG ;
Lip, GYH .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (05) :277-284
[5]   Immediate anticoagulation in acute focal brain ischemia revisited - Gathering the evidence [J].
Chamorro, A .
STROKE, 2001, 32 (02) :577-578
[6]   Heparin in acute stroke with atrial fibrillation -: Clinical relevance of very early treatment [J].
Chamorro, A ;
Vila, N ;
Ascaso, C ;
Blanc, R .
ARCHIVES OF NEUROLOGY, 1999, 56 (09) :1098-1102
[7]   Heparin in acute ischemic stroke: The case for a new clinical trial [J].
Chamorro, A .
CEREBROVASCULAR DISEASES, 1999, 9 :16-23
[8]   Antileukocyte adhesion therapy: preclinical trials and combination therapy [J].
Clark, WM ;
Zivin, JA .
NEUROLOGY, 1997, 49 (05) :S32-S38
[9]   POLYMORPHONUCLEAR LEUKOCYTES OCCLUDE CAPILLARIES FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION AND REPERFUSION IN BABOONS [J].
DELZOPPO, GJ ;
SCHMIDSCHONBEIN, GW ;
MORI, E ;
COPELAND, BR ;
CHANG, CM .
STROKE, 1991, 22 (10) :1276-1283
[10]   ASTROCYTES ARE THE PRIMARY SOURCE OF TISSUE FACTOR IN THE MURINE CENTRAL-NERVOUS-SYSTEM - A ROLE FOR ASTROCYTES IN CEREBRAL HEMOSTASIS [J].
EDDLESTON, M ;
DELATORRE, JC ;
OLDSTONE, MBA ;
LOSKUTOFF, DJ ;
EDGINGTON, TS ;
MACKMAN, N .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :349-358